FOLD FY 2018 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FOLDAmicus Therapeutics, Inc.

$5B

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$91M+147.1% YoY

Gross Profit

$77M84.2% margin

Operating Income

-$329M-360.3% margin

Net Income

-$349M-382.5% margin

EPS (Diluted)

$-1.88

Cash Flow

Operating Cash Flow

-$300M

Free Cash Flow

-$306M

Stock-Based Comp.

$29M

Balance Sheet

Total Assets

$790M

Total Liabilities

$447M

Stockholders' Equity

$343M

Cash & Equivalents

$80M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$91M	$37M	+147.1%
Gross Profit	$77M	$31M	+150.3%
Operating Income	-$329M	-$442M	+25.6%
Net Income	-$349M	-$284M	-22.9%